| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.04 |